Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mol Endocrinol ; 26(7): 1102-16, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22570336

RESUMO

As one of the nine hereditary neurodegenerative polyQ disorders, spinal and bulbar muscular atrophy (SBMA) results from a polyQ tract expansion in androgen receptor (AR). Although protein aggregates are the pathological hallmark of many neurodegenerative diseases, their direct role in the neurodegeneration is more and more questioned. To determine the early molecular mechanisms causing motor neuron degeneration in SBMA, we established an in vitro system based on the tetracycline-inducible expression of normal (AR20Q), the mutated, 51 glutamine-extended (AR51Q), or polyQ-deleted (AR0Q) AR in NSC34, a motor neuron-like cell line lacking endogenous AR. Although no intracellular aggregates were formed, the expression of the AR51Q leads to a loss of function characterized by reduced neurite outgrowth and to a toxic gain of function resulting in decreased cell viability. In this study, we show that both AR20Q and AR51Q are recruited to lipid rafts in response to testosterone stimulation. However, whereas testosterone induces the activation of the c-jun N-terminal kinase/c-jun pathway via membrane-associated AR20Q, it does not so in NSC34 expressing AR51Q. Phosphorylation of c-jun N-terminal kinase plays a crucial role in AR20Q-dependent survival and differentiation of NSC34. Moreover, c-jun protein levels decrease more slowly in AR20Q- than in AR51Q-expressing NSC34 cells. This is due to a rapid and transient inhibition of glycogen synthase kinase 3α occurring in a phosphatidylinositol 3-kinase-independent manner. Our results demonstrate that the deregulation of nongenomic AR signaling may be involved in SBMA establishment, opening new therapeutic perspectives.


Assuntos
Transtornos Musculares Atróficos/metabolismo , Receptores Androgênicos/metabolismo , Testosterona/metabolismo , Animais , Linhagem Celular , Quinase 3 da Glicogênio Sintase/antagonistas & inibidores , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Microdomínios da Membrana/metabolismo , Camundongos , Camundongos Transgênicos , Neurônios Motores/metabolismo , Peptídeos/metabolismo , Fosfatidilinositol 3-Quinase/metabolismo , Fosforilação , Transdução de Sinais
2.
Biochem Pharmacol ; 83(1): 37-46, 2012 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-21983033

RESUMO

7ß-Hydroxycholesterol cytotoxicity has been shown in vivo and in vitro to be dependent on the accumulation of its esters. We show in our study, using a detergent-free raft preparation and LC/MS lipid content analysis, that membrane microdomains isolated from 7ß-hydroxycholesterol-treated C6 cells have a reduced cholesterol: cholesterol ester ratio and accumulate 7keto-hydroxycholesterol, 7ß-hydroxycholesterol and 7ß-hydroxycholesterol esters. These modifications in lipid content are accompanied by a redistribution of flotillin-1 in the lipid rafts. Transient increases of AMPK phosphorylation and mitochondrial activity during the first 12 h of 7ß-hydroxycholesterol treatment indicate that C6 cells undergo energy stress and increase oxidative phosphorylation. Even so, ATP levels are maintained during 15 h until glucose uptake decreases. The cell's answers to raft modifications and energy stress are sequential activations of different signaling pathways such as ERK, AMPK and PI3K/Akt. These pathways, known to be activated under energy stress conditions, are transiently activated at 6 h (ERK, AMPK) and 12 h (Akt) of treatment respectively suggesting a shift from cell survival to cell proliferation. The persistence of 7ß-hydroxycholesterol-induced stress led after 24 h to P38 activation, loss of GSK3ß activation and to cell death. Finally we demonstrate that the observed signaling responses depend on 7ß-hydroxycholesterol esterification, confirming that esterification of 7ß-hydroxycholesterol is essential for cytotoxicity.


Assuntos
Metabolismo Energético/fisiologia , Glioblastoma/metabolismo , Hidroxicolesteróis/metabolismo , Microdomínios da Membrana/metabolismo , Transdução de Sinais/fisiologia , Animais , Bovinos , Morte Celular/efeitos dos fármacos , Morte Celular/fisiologia , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Metabolismo Energético/efeitos dos fármacos , Humanos , Hidroxicolesteróis/toxicidade , Microdomínios da Membrana/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...